QuickView for nuclear import signal receptor activity (biogroup)

1. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
3. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
5. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)

There were no matches for nuclear import signal receptor activity

1. NASH and Type 2 Diabetes: Role of the Receptor Activator of Nuclear Factor-κB (RANK) and Its Ligand …
2. Pathological and Nuclear Medicine Factors for Prognosis in Lung Carcinoma
3. GLP-1 Therapy: The Role of IL-6 Signaling and Adipose Tissue Remodeling in Metabolic Response
4. New Signaling Pathway Targeting Systemic Lupus Erythematosus
5. Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study